Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model-Reference-Cited by-同舟云学术

Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model

Published:2013-03 Issue:1-2 Volume:445 Page:171-180
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Roy Aniruddha,Singh Manu Smriti,Upadhyay Pramod,Bhaskar Sangeeta

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference30 articles.

1. Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment;Allavena;Clin. Exp. Immunol.,2012

2. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation;Danhier;J. Control Release,2009

3. Intratumoral administration of TLR4 agonist absorbed into a cellular vector improves antitumor responses;Davis;Clin. Cancer Res.,2011

4. Chemoimmunotherapy;Emens;Cancer J.,2010

5. Cancer relapse under chemotherapy: why TLR2/4 receptor agonists can help;Garay;Eur. J. Pharmacol.,2007

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances and applications of nanoparticles in cancer therapy;MedComm – Oncology;2024-03

2. Tumor targeted delivery of mycobacterial adjuvant encapsulated chitosan nanoparticles showed potential anti-cancer activity and immune cell activation in tumor microenvironment;International Immunopharmacology;2023-01

3. PLGA-based nanoparticles for enhanced diagnosis and cancer therapy;Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for Drug Delivery;2023

4. Nanoparticles for Chemoimmunotherapy Against Triple-Negative Breast Cancer;International Journal of Nanomedicine;2022-11

5. Cardiolipin for Enhanced Cellular Uptake and Cytotoxicity of Thermosensitive Liposome-Encapsulated Daunorubicin toward Breast Cancer Cell Lines;International Journal of Molecular Sciences;2022-10-04